- JP-listed companies
- TMS Co., Ltd
- Balance sheet
TMS Co., Ltd【JP:4891】Balance sheet
Market cap
¥6.2B
P/E ratio
Timbs Inc. develops anti-inflammatory drugs from black mold compounds, targeting diseases like stroke and inflammatory conditions through partnerships with major pharmaceutical companies.
| 2020/02 | 2021/02 | 2022/02 | 2023/02 | 2024/02 | 2025/02 | 2025/12 | |
| Cash and cash equivalents | - | 1,107 | 2,598 | 3,585 | 3,447 | 2,923 | 2,781 |
| Total cash & short-term investments | - | 1,107 | 2,598 | 3,585 | 3,447 | 2,923 | 2,781 |
| Total current assets | - | 1,213 | 2,723 | 3,767 | 3,552 | 3,029 | 2,864 |
| Property, plant and equipment, net | - | 0 | 4 | 12 | - | - | - |
| Total non-current assets | - | 1 | 17 | 24 | 3 | 3 | 2 |
| Total assets | - | 1,213 | 2,740 | 3,790 | 3,555 | 3,032 | 2,865 |
| Total current liabilities | - | 86 | 285 | 76 | 98 | 217 | 94 |
| Total non-current liabilities | - | - | 1 | - | - | - | - |
| Total liabilities | - | 86 | 287 | 76 | 98 | 217 | 94 |
| Retained earnings | - | -734 | 1,077 | 216 | -744 | -1,405 | -716 |
| Stockholders' equity | 749 | 1,127 | 2,453 | 3,714 | 3,457 | 2,815 | 2,771 |